Evaluation of endothelial barrier function in atherosclerosis induced rabbits using S-nitroso human serum albumin (S-NO-HSA) - blood pool agent compound and dynamic contrast-enhanced (DCE)-MRI
Peter Opriessnig1, Gunter Almer1, Harald Froehlich1, Claudia Cabella2, Rudolf Stollberger3, Seth Hallstroem4, Gerd Hoerl4, and Harald Mangge1

1Clinical Institute for Medical and Chemical Laboratory Diagnosis, Medical University of Graz, Graz, Austria, 2CRB Bracco Imaging SpA, Colleretto Giacosa, Torino, Italy, 3Institute of Medical Engineering, Graz University of Technology, Graz, Austria, 4Institute of Physiological Chemistry, Medical University of Graz, Graz, Austria

Synopsis

Endothelial dysfunction plays a key role in the progression and pathogenesis of atherosclerosis (AS). DCE-MRI in combination with a special nitric oxide donor S-nitroso human serum albumin (S-NO-HAS) blood pool agent (B22956/1) compound could be an additional measure that provides information on the influence of plaque burden on the vascular permeability and vasomotion. In this work, we demonstrate the feasibility to investigate endothelial barrier function and NO induced endothelium-independent vasomotor response of the abdominal aorta in control and AS induced rabbits simultaneously. Relative vessel wall signal enhancement and change in lumen area were measured using a double-inversion-recovery turbo-spin-echo sequence.

Purpose

As an early event, endothelial dysfunction is involved in the progression of atherosclerosis (AS). Gadolinium based blood pool agents were successfully applied in the past for fibrous plaque detection and to gain insight into the leakiness of the endothelial layer via the altered vascular permeability and albumin as vehicle into the lesion.1,2

In this work we set out to measure the endothelial barrier function of atherosclerotic rabbits using B-22956/1 an albumin binding agent in combination with NO donor S-nitroso human serum albumin (S-NO-HSA) and DCE-MRI. Furthermore, we tested whether the long-term S-NO-HSA-B22956/1 infusion led to a NO induced vasodilation effect.

Methods

B22956/1: Gadocoletic acid trisodium salt (Bracco Imaging SpA) is an intravascular high affinity serum albumin binding blood pool agent already applied to image neovessel- and macrophage- density in atherosclerotic rabbits.3

S-nitroso human serum albumin: A nitric oxide donor used for NO supplementation shown to prevent endothelial NO synthase (eNOS) uncoupling in rabbits.4

Animal model: A total of three male New Zealand White (NZW) rabbits (age:10-11months; body weight:3,5-4,5kg) were used repeatedly in this study. Abdominal aortic atherosclerosis was induced in two rabbits by a combination of balloon catheter denudation and a two month high cholesterol diet. The injury was performed from the iliac bifurcation to the renal artery bifurcation introducing a 4F wedge pressure balloon catheter through the carotid artery. One non-treated rabbit fed a normal chow diet was used as control.

S-NO-HSA(-B22956/1) infusion strategy: Either 18,5mL of B22956/1(2mM) pre-incubated with S-NO-HSA(1mM) or B22956/1(2mM) diluted in sodium chloride were administered intravenously during DCE-MRI. A slow infusion rate of 20mL/h was chosen for all experiments to prevent uncontrolled NO mediated hypotension. To assure contrast agent wash out from the vessel wall, experiments were separated by a whole week. For the injured rabbits the experiments were repeated two-to-three times ending up in a total of five-to-six imaging sessions.

Imaging: A dark blood double inversion recovery (DIR) T1-weighted turbo spin echo (T1w-TSE) sequence was used on one selected axial slice for DCE measurements. Scan parameter were TR/TE:600/12ms; NEX/ETL:4/7; matrix:256x176; FOV:120x82,5mm; resolution:0.46x0.46x3mm. To avoid chemical shift artifacts caused by peri-adventitial fat, a spectral fat saturation pulse was applied. A total of 60 images were acquired with a temporal resolution of 1min1sec. Before long-term infusion a total of five precontrast images were taken for baseline signal averaging. All experiments were performed on a human 3Tesla platform (Siemens Magnetom Prisma) using a 15Ch TxRx knee coil.

Data analysis: Inner and outer vessel wall boundaries of DCE images were manually segmented using ITK-SNAP. To uncover possible NO mediated wall relaxation effects boundaries were used to calculate lumen areas over time. Average vessel wall signal intensities (SI) were calculated for each DCE time point. In addition, the normalized wall index (NWI=wall area/total vessel area) was calculated as a measure of wall thickening. The relative signal enhancement c(t) was calculated by subtracting the signal intensity SI(t) at a given time point from the baseline tissue signal intensity SI(0) according to equation5: c(t)=(SI(0)-SI(t))/SI(0).

Results

Figure 1 shows the relative vessel wall signal enhancement c(t) during the long-term infusion of S-NO-HSA-B22956/1 (green line) and B22956/1 (blue line), respectively. The relative change in lumen area is outlined in Figure 2. A representative T1w image together with the NWI is illustrated in Figure 3. Given that a delayed wall enhancement (decreased vascular permeability) and vasodilation of the NO donor carrying compound can be observed, a regulation of the endothelial barrier function as well as an NO induced endothelium-independent vasomotor response of the control (CTRL) rabbits’ vessel is assumable. For the balloon treated NZW I (BT-NZW I) no differences in wall enhancement but an NO triggered relaxation of the artery can be observed, indicating that a vascular damage with endothelial dysfunction but existing vasorelaxation of smooth muscle cells is assumable. BT-NZW II with a prominent thickening of the wall (NWI=0.56) shows a reconstituted delayed endothelial function and contraction of the artery, assuming advanced plaque burden with possible endothelial regrowth and paradoxical NO induced vasoconstriction.

Discussion and Conclusion

In this work, we demonstrate for the first time the feasibility to investigate vascular permeability and NO induced endothelium-independent vasomotor response of the abdominal aorta in control and balloon denuded rabbits simultaneously. The role of NO in controlling the interendothelial junctions and therefore to regulate the endothelial barrier is discussed quite controversial in literature but our data assume specific patterns depending on the degree of plaque burden. Future work will investigate the influence of plaque progression on endothelial barrier regulation and vasomotion which may help to predict the formation of atherosclerotic plaques.

Acknowledgements

Supported by European Union's FP7 funded Project NanoAthero (grant agreement no 309820).

References

1. Meding J, Urich M, Licha K, et al. Magnetic resonance imaging of atherosclerosis by targeting extracellular matrix deposition with Gadofluorine M. Contrast Media Mol Imaging. 2007;2(3):120-129. 2. Phinikaridou A, Andia ME, Protti A, et al. Noninvasive magnetic resonance imaging evaluation of endothelial permeability in murine atherosclerosis using an albumin-binding contrast agent. Circulation. 2012;126(6):707-719. 3. Cornily JC, Hyafil F, Calcagno C, et al. Evaluation of neovessels in atherosclerotic plaques of rabbits using an albumin-binding intravascular contrast agent and MRI. J Magn Reson Imaging. 2008;27(6):1406-1411. 4. Hallström S, Gasser H, Neumayer C, et al. S-nitroso human serum albumin treatment reduces ischemia/reperfusion injury in skeletal muscle via nitric oxide release. Circulation. 2002;105(25):3032-3038. 5. Sourbron S, Ingrisch M, Siefert A, et al. Quantification of cerebral blood flow, cerebral blood volume, and blood–brain-barrier leakage with DCE-MRI. Magn Reson Med. 2009;62(1):205-217.

Figures

Signal analysis of DCE vessel wall frames administered B22956/1 (blue line) and S-NO-HSA-B22956/1 (green line). Graph shows the calculated relative vessel wall signal enhancement c(t) of control (CTRL, one imaging session per compound) and balloon treated rabbits (BT-NZW I & II, average values of three repeated imaging sessions per compound per rabbit; except for case BT-NZW II: two sessions of NO carrying compound) using a DIR-T1w-TSE sequence with a temporal resolution of 1min1sec.

Relative change in lumen area vs time curve of control and injured rabbits representing vaso-relaxation and constriction effects of the abdominal aorta upon B22956/1 (blue line) and S-NO-HSA-B22956/1 (green line) administration.

Representative T1w DCE image together with the normalized wall index (NWI).



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
0965